Published in FEBS Lett on November 16, 1992
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Unusual solution properties of proline and its interaction with proteins. Biochim Biophys Acta (1978) 1.94
Synaptophysin: molecular organization and mRNA expression as determined from cloned cDNA. EMBO J (1987) 1.93
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82
Molecular cloning and sequence analysis of the X-prolyl dipeptidyl aminopeptidase gene from Lactococcus lactis subsp. cremoris. Appl Environ Microbiol (1991) 1.72
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J (1994) 1.68
Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J (1989) 1.55
The effect of nisin on murein synthesis. Arch Microbiol (1980) 1.53
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol (1996) 1.52
A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett (1992) 1.51
Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J (1993) 1.49
Structural properties of matrix metalloproteinases. Cell Mol Life Sci (1999) 1.43
Nucleotide sequence of cDNA clones encoding the complete precursor for the "10-kDa" polypeptide of photosystem II from spinach. J Biol Chem (1988) 1.36
Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochem J (1993) 1.32
The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells. Anticancer Res (2000) 1.32
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study. FEBS Lett (1994) 1.32
Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum (1986) 1.28
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem (2000) 1.24
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Insights into MMP-TIMP interactions. Ann N Y Acad Sci (1999) 1.18
Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. Eur J Biochem (1983) 1.18
The sodium ion translocating oxalacetate decarboxylase of Klebsiella pneumoniae. Sequence of the biotin-containing alpha-subunit and relationship to other biotin-containing enzymes. J Biol Chem (1988) 1.16
The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. Eur J Biochem (2001) 1.15
X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur J Biochem (1995) 1.15
Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett (1995) 1.14
Regulation of circadian gene expression in liver by systemic signals and hepatocyte oscillators. Cold Spring Harb Symp Quant Biol (2007) 1.14
Interleukin-8 synthesis and the onset of labor. Obstet Gynecol (1995) 1.12
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem (2000) 1.11
Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J (1994) 1.09
Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. J Mol Biol (2001) 1.08
Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2. J Mol Biol (2006) 1.07
The primary structure of porcine glandular kallikreins. Adv Exp Med Biol (1979) 1.06
Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms. Eur J Biochem (1990) 1.05
Enzyme linked immunosorbent assays (ELISA) for the quantitative determination of human leukocyte collagenase and gelatinase. J Clin Chem Clin Biochem (1989) 1.05
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot. Models for collagen catabolism by matrix-metalloproteases. FEBS Lett (1996) 1.04
Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer. Br J Cancer (1995) 1.03
Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J (1993) 1.03
Sequence and expression of the glycosyl-phosphatidylinositol-specific phospholipase C of Trypanosoma brucei. Mol Biochem Parasitol (1989) 1.02
Origin of cervical collagenase during parturition. Am J Obstet Gynecol (1992) 1.02
Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor. Biochemistry (1995) 1.01
Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol (1995) 1.00
The solution structure and dynamics of human neutrophil gelatinase-associated lipocalin. J Mol Biol (1999) 0.99
The refined 2.2-A (0.22-nm) X-ray crystal structure of the ternary complex formed by bovine trypsinogen, valine-valine and the Arg15 analogue of bovine pancreatic trypsin inhibitor. Eur J Biochem (1984) 0.99
Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase. FEBS Lett (1990) 0.98
The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2. FEBS Lett (1996) 0.97
Degradation of kinins, angiotensins and substance P by polymorphonuclear matrix metalloproteinases MMP 8 and MMP 9. Braz J Med Biol Res (1994) 0.96
Lantent collagenase from human polymorphonuclear leucocytes and activation to collagenase by removal of a inhibitor. FEBS Lett (1980) 0.96
A non-thalamic pathway contributes to a whole body map in the brain of the budgerigar. Brain Res (1997) 0.94
C-terminal-sequence determination by carboxypeptidase C from orange levels. Eur J Biochem (1972) 0.92
Carbon-13 nuclear magnetic resonance studies of the selectively isotope-labeled reactive site peptide bond of the basic pancreatic trypsin inhibitor in the complexes with trypsin, trypsinogen, and anhydrotrypsin. Biochemistry (1980) 0.92
The collagenase inhibitor from human polymorphonuclear leukocytes. Isolation, purification and characterisation. Eur J Biochem (1983) 0.92
The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity. Biochem Biophys Res Commun (1993) 0.92
Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis. FEBS Lett (1997) 0.92
Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. Mol Carcinog (1998) 0.90
[Properties of the trypsin-like (acrosin) from boar spermatozoa]. Hoppe Seylers Z Physiol Chem (1972) 0.90
Stability studies on derivatives of the bovine pancreatic trypsin inhibitor. Biochemistry (1987) 0.90
Mercurial activation of human polymorphonuclear leucocyte procollagenase. Eur J Biochem (1991) 0.90
Biochemical events in cervical ripening dilatation during pregnancy and parturition. J Obstet Gynaecol (Tokyo 1995) (1995) 0.89
Characterisation of beta 1-anticollagenase from human plasma and its reaction with polymorphonuclear leukocyte collagenase by disulfide/thiol interchange. Eur J Biochem (1983) 0.89
Transforming growth factor beta 1 regulates tissue inhibitor of metalloproteinases-1 expression in differentiated human articular chondrocytes. Arthritis Rheum (1994) 0.89
Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma. J Biol Chem (1999) 0.89
Isolation and characterization of an oligosaccharide- and glycoprotein-specific sialidase from human leucocytes. Hoppe Seylers Z Physiol Chem (1984) 0.88
The sodium ion translocating oxaloacetate decarboxylase of Klebsiella pneumoniae. Sequence of the integral membrane-bound subunits beta and gamma. J Biol Chem (1989) 0.88
Cloning and expression in Pichia pastoris of metalloprotease domain of ADAM 9 catalytically active against fibronectin. Protein Expr Purif (2001) 0.87
Proteases and their inhibitors are indicative in gestational disease. Eur J Obstet Gynecol Reprod Biol (1996) 0.87
Preparation and characterization of the active derivative bovine trypsin-kallikrein inhibitor (Kunitz) with the reactive site lysine-15 -- alanine-16 hydrolyzed. Eur J Biochem (1976) 0.86
Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clin Chem (1998) 0.86
Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2). Up-regulation by interleukin-6 and transforming growth factor beta 1. FEBS Lett (1992) 0.86
Induction of bilateral plasticity in sensory cortical maps by small unilateral cortical infarcts in rats. Eur J Neurosci (2003) 0.86
Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid. FEBS Lett (1992) 0.86
Hydrolysis-resynthesis equilibrium of the lysine-15--alanine-16 peptide bond in bovine trypsin inhibitor (Kunitz). Hoppe Seylers Z Physiol Chem (1976) 0.84
N-Acetylalanine aminopeptidase, a new enzyme from human erythrocytes. Hoppe Seylers Z Physiol Chem (1981) 0.84
Parturition at term: parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment. Hum Reprod (1999) 0.84
Porcine glandular kallikreins. Methods Enzymol (1981) 0.83
Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol (1996) 0.83
Potentiative effects of neutral proteinases in an inflamed lung: relationship of neutrophil procollagenase (proMMP-8) to plasmin, cathepsin G and tryptase in bronchiectasis in vivo. Eur Respir J (1997) 0.83
Determination of arginine in the reactive site of proteinase inhibitors by selective and reversible derivatization of the arginine side chain. Hoppe Seylers Z Physiol Chem (1976) 0.83
Semisynthetic engineering of proteinase inhibitor homologues. Biochim Biophys Acta (1987) 0.83
A highly sensitive immunoenzymometric assay for the determination of angiogenin. Eur J Clin Chem Clin Biochem (1993) 0.83
Activation of human neutrophil procollagenase by stromelysin 2. Eur J Biochem (1996) 0.83
Inactivation of human plasma C1-inhibitor by human PMN leucocyte matrix metalloproteinases. FEBS Lett (1991) 0.83
In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol (1994) 0.83
A sandwich enzyme immunoassay for the determination of neutrophil lipocalin in body fluids. Clin Chim Acta (1995) 0.82
Stopped-flow kinetics of the resynthesis of the reactive site peptile bond in kallikrein inhibitor (Kunitz) by beta-trypsin. Biochemistry (1978) 0.82
Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. Biol Chem (2001) 0.82
MMP-TIMP interaction depends on residue 2 in TIMP-4. FEBS Lett (2001) 0.82
Collagenolysis in the lower uterine segment during parturition at term: correlations with stage of cervical dilatation and duration of labor. Am J Obstet Gynecol (1999) 0.82